NCT07663786进行中（未招募）不适用
ENDURANCE: Evaluation of Esophagogastric Cancer Treatment With Nivolumab in Dutch Daily Clinical Practice. Part B1
Bristol-Myers Squibb1 个研究点 分布在 1 个国家目标入组 726 人开始时间: 2025年10月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 726
- 试验地点
- 1
研究概览
简要总结
This study uses existing cancer registry and health record data to understand how nivolumab is used in routine care in the Netherlands for adults with advanced cancers of the esophagus, gastroesophageal junction, or stomach.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Registered in the Netherlands Cancer Registry (NCR)
- •Diagnosed with Esophageal Adenocarcinoma (EAC), Gastro-esophageal Junction Adenocarcinoma (GEJAC), or Gastric Adenocarcinoma (GAC) from 01-Aug-2022 to 31-Jul-2024
- •Age ≥18 years at diagnosis
- •Unresectable advanced (cT4B) or synchronous metastatic (cM1) disease at diagnosis
- •(Cohort 2) Programmed cell Death Ligand 1 (PD-L1) CPS ≥5
- •(Cohort 3) Received nivolumab as part of first-line treatment
排除标准
- •Neuro-endocrine carcinomas or non-epithelial cancers of esophagus/ gastroesophageal junction /stomach
- •Positive HER2 expression
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
1 期
The clinical trial to study the effects of Naptumomab Estafenatox in Combination with Durvalumab (MEDI4736) in Subjects with Selected Advanced or Metastatic Solid TumorsCTRI/2025/03/081639NeoTX Therapeutics Ltd54
招募中
2 期
Becotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCCNCT07403136Fudan University104
招募中
3 期
Ramucirumab plus Irinotecan / Leucovorin / 5-FU versus Ramucirumab plus Paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy - The Phase II/III RAMIRIS STUDY2024-512934-14-00Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH319
尚未招募
2 期
Precision Medicine for Immunotherapy-Resistant Advanced Esophageal CancerEsophageal Squamous Cell CarcinomaNCT07653451Peking University Cancer Hospital & Institute90
招募中
1 期
MR-Guided Radiotherapy Dose Escalation Trial for Esophageal Squamous Cell CarcinomaNCT07359417UMC Utrecht30